yttrium Y 90 ibritumomab tiuxetan

Yttrium Y 90 ibritumomab tiuxetan, also known as IDEC-Y2B8 monoclonal antibody, is an anticancer drug. It is a combination of the radioisotope yttrium-90 and a monoclonal antibody, a produced substance that can locate and bind to cancer cells. Once attached to a cell, it can either kill it or deliver radioactive cancer-killing substances to it without harming normal cells.
See more at Wikipedia.org...

An anticancer drug that is a combination of a monoclonal antibody and a radioisotope (yttrium-90). Monoclonal antibodies are laboratory-produced substances that can locate and bind to cancer cells. Also called IDEC-Y2B8 monoclonal antibody.